Your browser doesn't support javascript.
Intimate Partner Violence During COVID-19 Restrictions: A Study of 30 Countries From the I-SHARE Consortium.
Campbell, Linda; Tan, Rayner K J; Uhlich, Maximiliane; Francis, Joel M; Mark, Kristen; Miall, Naomi; Eleuteri, Stefano; Gabster, Amanda; Shamu, Simukai; Plásilová, Leona; Kemigisha, Elizabeth; Olumide, Adesola; Kosana, Priya; Hurtado-Murillo, Felipe; Larsson, Elin C; Cleeve, Amanda; Calvo González, Soraya; Perrotta, Gabriela; Fernández Albamonte, Victoria; Blanco, Lucía; Schröder, Johanna; Adebayo, Adedamola; Hendriks, Jacqueline; Saltis, Hanna; Marks, Michael; Wu, Dan; Morroni, Chelsea; Esho, Tammary; Briken, Peer; Hlatshwako, Takhona Grace; Ryan, Rebecca; Farid, Nik Daliana Nik; Gomez Bravo, Raquel; Van de Velde, Sarah; Tucker, Joseph D.
  • Campbell L; Center for Population, Family, and Health, University of Antwerp, Belgium.
  • Tan RKJ; Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, University of Ghent, Belgium.
  • Uhlich M; Dermatology Hospital of Southern Medical University, Guangzhou, China.
  • Francis JM; University of North Carolina Project, Guangzhou, China.
  • Mark K; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
  • Miall N; Department of Psychology, University of Basel, Switzerland.
  • Eleuteri S; Department of Family Medicine and Primary Care, School of Clinical Medicine, University of Witwatersrand, Johannesburg, South Africa.
  • Gabster A; Institute for Sexual and Gender Health, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Shamu S; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Plásilová L; Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
  • Kemigisha E; Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama.
  • Olumide A; National Research System, National Secretariat of Science, Technology and Innovation, Panama City, Panama.
  • Kosana P; Center of Population Sciences for Health Equity, Florida State University, Tallahassee, FL, USA.
  • Hurtado-Murillo F; Health Systems Strengthening Division, Foundation for Professional Development, Pretoria, South Africa.
  • Larsson EC; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Cleeve A; Department of Psychology and Life Sciences, Faculty of Humanities, Charles University, Prague, Czech Republic.
  • Calvo González S; Laboratory of Evolutionary Sexology and Psychopathology, National Institute of Mental Health, Klecany, Czech Republic.
  • Perrotta G; Mbarara University of Science and Technology, Mbarara, Uganda.
  • Fernández Albamonte V; Institute of Child Health, College of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
  • Blanco L; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Schröder J; Center for Sexual and Reproductive Health, University Hospital Doctor Peset, Valencia, Spain.
  • Adebayo A; Karolinska Institutet, Department of Global Health and Department of Women's and Children's Health, Stockholm, Sweden.
  • Hendriks J; Karolinska Institutet, Department of Global Health and Department of Women's and Children's Health, Stockholm, Sweden.
  • Saltis H; South General Hospital, Stockholm, Sweden.
  • Marks M; Department of Education Sciences, University of Oviedo, Oviedo, Spain.
  • Wu D; Faculty of Psychology, University of Buenos Aires, Buenos Aires, Argentina.
  • Morroni C; Faculty of Psychology, University of Buenos Aires, Buenos Aires, Argentina.
  • Esho T; Faculty of Psychology, University of Buenos Aires, Buenos Aires, Argentina.
  • Briken P; Institute for Sex Research, Sexual Medicine and Forensic Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hlatshwako TG; Institute of Child Health, University of Ibadan, Ibadan, Nigeria.
  • Ryan R; Collaboration for Evidence, Research and Impact in Public Health, School of Population Health, Curtin University, Perth, Australia.
  • Farid NDN; Collaboration for Evidence, Research and Impact in Public Health, School of Population Health, Curtin University, Perth, Australia.
  • Gomez Bravo R; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Van de Velde S; Hospital for Tropical Diseases, University College London Hospital, London, UK.
  • Tucker JD; Division of Infection and Immunity, University College London, London, UK.
J Interpers Violence ; 38(11-12): 7115-7142, 2023 06.
Article in English | MEDLINE | ID: covidwho-2224001
ABSTRACT
Intimate partner violence (IPV) causes substantial physical and psychological trauma. Restrictions introduced in response to the COVID-19 pandemic, including lockdowns and movement restrictions, may exacerbate IPV risk and reduce access to IPV support services. This cross-sectional study examines IPV during COVID-19 restrictions in 30 countries from the International Sexual HeAlth and REproductive Health (I-SHARE) study conducted from July 20th, 2020, to February, 15th, 2021. IPV was a primary outcome measure adapted from a World Health Organization multicountry survey. Mixed-effects modeling was used to determine IPV correlates among participants stratified by cohabitation status. The sample included 23,067 participants from 30 countries. A total of 1,070/15,336 (7.0%) participants stated that they experienced IPV during COVID-19 restrictions. A total of 1,486/15,336 (9.2%) participants stated that they had experienced either physical or sexual partner violence before the restrictions, which then decreased to 1,070 (7.0%) after the restrictions. In general, identifying as a sexual minority and experiencing greater economic vulnerability were associated with higher odds of experiencing IPV during COVID-19 restrictions, which were accentuated among participants who were living with their partners. Greater stringency of COVID-19 restrictions and living in urban or semi-urban areas were associated with lower odds of experiencing IPV in some settings. The I-SHARE data suggest a substantial burden of IPV during COVID-19 restrictions. However, the restrictions were correlated with reduced IPV in some settings. There is a need for investing in specific support systems for survivors of IPV during the implementation of restrictions designed to contain infectious disease outbreaks.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sexual Health / Intimate Partner Violence / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: J Interpers Violence Journal subject: Social Sciences Year: 2023 Document Type: Article Affiliation country: 08862605221141865

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sexual Health / Intimate Partner Violence / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: J Interpers Violence Journal subject: Social Sciences Year: 2023 Document Type: Article Affiliation country: 08862605221141865